Haofei Hong

526 total citations
45 papers, 418 citations indexed

About

Haofei Hong is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Haofei Hong has authored 45 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in Haofei Hong's work include Glycosylation and Glycoproteins Research (32 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Biochemical and Structural Characterization (16 papers). Haofei Hong is often cited by papers focused on Glycosylation and Glycoproteins Research (32 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Biochemical and Structural Characterization (16 papers). Haofei Hong collaborates with scholars based in China, United States and Netherlands. Haofei Hong's co-authors include Zhimeng Wu, Zhifang Zhou, Jie Shi, Lin Han, Liang Gong, Xinrui Zhao, Kun Zhou, Zhaohui Huang, Yanchun Li and Dan Li and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Scientific Reports.

In The Last Decade

Haofei Hong

40 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haofei Hong China 14 286 170 106 95 50 45 418
Hervé Nozach France 13 184 0.6× 132 0.8× 64 0.6× 72 0.8× 25 0.5× 23 354
Ina Theobald Germany 6 336 1.2× 197 1.2× 66 0.6× 66 0.7× 23 0.5× 7 459
Yong Yin China 5 265 0.9× 126 0.7× 42 0.4× 62 0.7× 33 0.7× 6 432
Arnaud Briat France 13 235 0.8× 77 0.5× 30 0.3× 128 1.3× 31 0.6× 23 440
Susan Morey United States 7 207 0.7× 83 0.5× 154 1.5× 80 0.8× 61 1.2× 10 359
Natalia I. Majewska United States 9 464 1.6× 155 0.9× 59 0.6× 29 0.3× 27 0.5× 12 525
Fabian Higel Germany 8 428 1.5× 252 1.5× 141 1.3× 48 0.5× 59 1.2× 14 531
Anna Robotham Canada 13 355 1.2× 114 0.7× 62 0.6× 32 0.3× 66 1.3× 25 472
Gavin Teo Singapore 10 352 1.2× 122 0.7× 36 0.3× 38 0.4× 40 0.8× 13 418
Stephan Dickgießer Germany 12 277 1.0× 222 1.3× 42 0.4× 130 1.4× 33 0.7× 20 369

Countries citing papers authored by Haofei Hong

Since Specialization
Citations

This map shows the geographic impact of Haofei Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haofei Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haofei Hong more than expected).

Fields of papers citing papers by Haofei Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haofei Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haofei Hong. The network helps show where Haofei Hong may publish in the future.

Co-authorship network of co-authors of Haofei Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Haofei Hong. A scholar is included among the top collaborators of Haofei Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haofei Hong. Haofei Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chen, et al.. (2025). Macrocyclic RGD-peptides with high selectivity for α v β 3 integrin in cancer imaging and therapy. RSC Medicinal Chemistry. 16(7). 3077–3083. 4 indexed citations
3.
Hong, Haofei, Jie Zhao, Kun Zhou, et al.. (2024). Rhamnose modified antibodies show improved immune killing towards EGFR-positive solid tumor cells. Carbohydrate Research. 536. 109038–109038. 5 indexed citations
4.
Zhang, Ranran, Dan Li, Zhifang Zhou, et al.. (2024). Chemo‐Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target‐specific Drug Delivery. ChemBioChem. 25(22). e202400512–e202400512. 4 indexed citations
5.
Li, Yanchun, Lin Han, Haofei Hong, et al.. (2024). Multivalent Rhamnose‐Modified EGFR‐Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies. Advanced Science. 11(13). e2307613–e2307613. 8 indexed citations
6.
Li, Yanchun, Dan Li, Lin Han, et al.. (2024). Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation. Journal of Controlled Release. 378. 18–26. 1 indexed citations
7.
Hong, Haofei, Kun Zhou, Lin Han, Yanchun Li, & Zhimeng Wu. (2024). In Situ Self‐Assembly of Antibody‐Rhamnose Complex as a Pre‐Targeting Strategy for Enhanced Cancer Immunotherapy. Chemistry - A European Journal. 31(1). e202403539–e202403539.
8.
Han, Lin, Yanchun Li, Kun Zhou, et al.. (2023). Supramolecular complex glycoconjugate vaccine generates self-enhancement effects for carbohydrate antigen delivery. Chinese Chemical Letters. 35(2). 108670–108670. 3 indexed citations
9.
10.
Liu, Zhicheng, Xia Li, Haofei Hong, et al.. (2022). Repurposing the Pentameric B-Subunit of Shiga Toxin for Gb3-Targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation. Journal of Pharmaceutical Sciences. 111(10). 2719–2729. 4 indexed citations
11.
Hong, Haofei, Lin Han, Dan Li, et al.. (2022). Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy. Angewandte Chemie. 134(38). 4 indexed citations
12.
Liu, Jinlong, Haofei Hong, Jie Shi, et al.. (2021). Dinitrophenol-mediated modulation of an anti-PD-L1 VHH for Fc-dependent effector functions and prolonged serum half-life. European Journal of Pharmaceutical Sciences. 165. 105941–105941. 14 indexed citations
13.
Hong, Haofei, et al.. (2020). GM3 trisaccharide biosynthesis and process optimization using engineered E. coli lysate and whole-cell catalysis. Journal of Carbohydrate Chemistry. 39(5-6). 217–231. 1 indexed citations
14.
Shen, Peng, et al.. (2020). Rapid assembly of phosphate-bridged tetra-mannose by ionic liquid-supported oligosaccharide synthesis. Carbohydrate Research. 500. 108209–108209. 3 indexed citations
15.
Tang, Feng, Wei Shi, Haofei Hong, et al.. (2019). One-step immobilization and purification of genetic engineering CBD fusion EndoS on cellulose for antibodies Fc-glycan remodeling. Bioorganic Chemistry. 91. 103114–103114. 14 indexed citations
17.
Wu, Zhimeng, et al.. (2017). New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation. Bioorganic & Medicinal Chemistry Letters. 27(9). 1911–1913. 9 indexed citations
18.
Zhao, Xinrui, Haofei Hong, & Zhimeng Wu. (2017). Efficient extracellular expression of transpeptidase sortase A in Pichia pastoris. Protein Expression and Purification. 133. 132–138. 4 indexed citations
19.
Wu, Zhimeng, Haofei Hong, Xinrui Zhao, & Xun Wang. (2017). Efficient expression of sortase A from Staphylococcus aureus in Escherichia coli and its enzymatic characterizations. Bioresources and Bioprocessing. 4(1). 13–13. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026